Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PHATthis companyPhathom Pharmaceuticals, Inc.	$5.26	-5.48×	-2.76×	6.91×	-8.47×	-248.1%	87.1%	-91.4%	-126.3%	50.5%	-125.2%	-13.8%	-0.48×	-0.54×	-2.35×	1.73×	0.0%	2	-4.79	2	C
ARDXArdelyx, Inc.	$2.96	-22.42×	8.42×	3.45×	-53.09×	-5941.7%	89.5%	-10.1%	-15.1%	-36.9%	-9.9%	-3.1%	1.27×	-4.92×	-1.44×	4.31×	0.0%	2	-0.11	1	D+
Peer median	—	-22.42×	8.42×	3.45×	-53.09×	-5941.7%	89.5%	-10.1%	-15.1%	-36.9%	-9.9%	-3.1%	1.27×	-4.92×	-1.44×	4.31×	0.0%	2	-0.11	1	—